Every time Vertex Pharmaceuticals (VTKX) becomes as technically oversold as it is now, it bounces back strong. In fact, if you pull up a one-year chart of VRTX, with RSI, MACD, and Williams’ %R, you’ll see that when these indicators all drop into oversold territory,...
On July 16, we noted, “Apple looks interesting. Last trading at $210.40, we’d like to see the tech giant break above triple top resistance with a near-term bearish gap refill at around $220. Helping, analysts at Jefferies just raised their price target on Apple to...
Just a few weeks ago, we said, “After a brief pullback, shares of Advanced Micro Devices (AMD) are just starting to pivot higher again. Last trading at $157.10, we’d like to see the stock test $175, near-term. Helping, AMD Executive Vice President and Chief...
by Ian Cooper The artificial intelligence boom shows no signs of cooling. Instead, it’s still heating up – with companies spending billions in capex on AI opportunities. In fact, Alphabet just announced it will boost its capital-expenditure forecast for the year to...
President Trump just said he might reclassify cannabis as having a lower danger level. On that news, shares of Canopy Growth (CGC) jumped more than 26%. Trulieve (TRUL) jumped 36%. And Tilray (TLRY) closed the day up about 42%. While impressive, all could see higher...
Keep an eye on lesser-known obesity drug stocks, like Viking Therapeutics (VKTX). Just days ago, Eli Lilly reported that its experimental weight loss pill helped patients lose about 11% of their body weight. However, that landed at the lower end of Wall Street’s...
After gapping from about $120 to $86.67, UPS (UPS) now sits at 2020 lows. All thanks to recent earnings and pulled guidance. In its most recent quarter, UPS’ EPS of $1.55 missed by two cents. Revenue of $21.2 billion, down 2.8% year over year, did beat by $350...
Ahead of the 2025 NFL season, gambling stocks, like DraftKings (SYM: DKNG) are exploding. Just as it did in 2024. A year ago, the American Gaming Association said Americans were expected to spend about $35 billion on NFL games this year. That’s up from the...
Keep an eye on Halozyme Therapeutics (HALO). Last trading at $60.81, we’d like to see it refill its bearish gap at around $64 initially. Helping, analysts at Morgan Stanley just upgraded HALO to overweight with a price target of $75. The firm believes the...
by Ian Cooper Last trading just above $114,000, Bitcoin could race to $150,000, even $200,000 this year. Of course, most of that is because of growing institutional and retail interest. However, thanks to bullish Trump plans and policies, the cryptocurrency could...